Eaton Vance Worldwide Health Sciences Fund Class I (EIHSX) - Health fund with $762.79 Million in assets. The fund allocates 54.72% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.
The largest holding in the fund is Eli Lilly Co at 11.33% of total assets. This is followed by UnitedHealth Group Inc (3.74%) and Novo Nordisk A/S (3.43%).
| Name | Weight | Owned | Change |
|---|---|---|---|
| Eli Lilly Co | 11.33% | - | - |
| UnitedHealth Group Inc | 3.74% | - | - |
| Novo Nordisk A/S | 3.43% | - | - |
| AbbVie Inc | 6.66% | - | - |
| AstraZeneca PLC | 6.54% | - | - |
| Thermo Fisher Scientific Inc | 3.45% | - | - |
| Danaher Corp | 3.81% | - | - |
| Roche Holding AG | 5.85% | - | - |
| Intuitive Surgical Inc | 3.63% | - | - |
| Johnson Johnson | 6.28% | - | - |
| Abbott Laboratories | 4.15% | - | - |
| Bristol-Myers Squibb Co | 4.10% | - | - |
| Zoetis Inc | 3.45% | - | - |
| Merck Co Inc | 4.43% | - | - |
| Vertex Pharmaceuticals Inc | 3.51% | - | - |
| Gilead Sciences Inc | 3.27% | - | - |